pre-IPO PHARMA

COMPANY OVERVIEW

Vidac is a clinical stage innovative biopharmaceutical company dedicated to discovering and developing first-in-class medicines to help people suffering from a range of oncologic and dermatologic medical conditions.


LOCATION

  • Har Hotzvim, Jerusalem, Israel
  • Brookline, MA, USA

  • THERAPEUTIC AREAS

  • Dermatology
  • Oncology
  • Rare Diseases

  • WEBSITE

    https://www.vidacpharma.com


    CAREER WEBSITE

    None


    SOCIAL MEDIA


    INVESTORS

    israel-biotech-fund mivtach-shamir-holdings


    PRESS RELEASES


    Jul 10, 2018

    Vidac Pharma Announces Initiation of Phase 2b Clinical Trial of VDA-1102 Ointment in Patients with Actinic Keratosis


    Oct 12, 2017

    Vidac Pharma Reports Positive Results from Phase 2a Proof-of-Concept Trial of VDA-1102 Ointment in Actinic Keratosis


    Jun 29, 2016

    Vidac Pharma Completes $9 Million Series A Financing


    For More Press Releases


    Google Analytics Alternative